David Kliman
Impact in
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
-
- Polyomavirus and related diseases
- CAR-T cell therapy research
Papers in
- Hematology 10
- Hematopoietic Stem Cell Transplantation 9
- Acute Myeloid Leukemia Research 5
- Genetics 6
- Chronic Lymphocytic Leukemia Research 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Co-authors
- David Gottlieb (7 shared papers)Emily Blyth (5 shared papers)Barbara Withers (4 shared papers)Leighton Clancy (4 shared papers)Kenneth Micklethwaite (3 shared papers)Ming‐Celine Dubosq (2 shared papers)David Bishop (2 shared papers)Jane Burgess (1 shared paper)
In The Last Decade
David Kliman
28 papers receiving 263 citations
Peers
Comparison fields: 5 of 39
- Hematology 69
- Oncology 100
- Transplantation 9
- Epidemiology 102
- Immunology 40
Countries citing papers authored by David Kliman
This map shows the geographic impact of David Kliman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Kliman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Kliman more than expected).
Fields of papers citing papers by David Kliman
This network shows the impact of papers produced by David Kliman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Kliman. The network helps show where David Kliman may publish in the future.
Co-authors
The 25 scholars most cited alongside David Kliman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 106 | |
| 2 | 2018 | 36 | |
| 3 | 2021 | 33 | |
| 4 | 2020 | 12 | |
| 5 | 2014 | 10 | |
| 6 | 2022 | 6 | |
| 7 | 2019 | 5 | |
| 8 | 2018 | 5 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 4 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 4 | |
| 13 | 2022 | 4 | |
| 14 | 2009 | 4 | |
| 15 | 2015 | 3 | |
| 16 | 2024 | 3 | |
| 17 | 2020 | 3 | |
| 18 | 2020 | 3 | |
| 19 | 2016 | 3 | |
| 20 | 2024 | 3 |
About David Kliman
David Kliman is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 29 papers that have together received 266 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (9 papers), Acute Lymphoblastic Leukemia research (6 papers), Acute Myeloid Leukemia Research (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Cytomegalovirus and herpesvirus research (3 papers), Galectins and Cancer Biology (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (69 citations), Oncology (100 citations), Transplantation (9 citations), Epidemiology (102 citations) and Immunology (40 citations). David Kliman has collaborated with scholars based in Australia, Canada and China. Frequent co-authors include David Gottlieb, Emily Blyth, Barbara Withers, Leighton Clancy, Kenneth Micklethwaite, Ming‐Celine Dubosq, David Bishop, Jane Burgess, Chris Fraser and Agnes S. M. Yong. Their work appears in journals such as Blood, Bone Marrow Transplantation, Journal of Clinical Oncology, Biology of Blood and Marrow Transplantation and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.